Objective: The present study aimed to evaluate whether baseline insulin resistance (IR) modify weight change associated to glycemic index (GI) of the diet. Method: This is a secondary analysis of a randomized GI intervention according to baseline HOMA-IR. Middle-aged (25–45 years), non-obese (BMI 23–29.9 kg/m2) women were randomized to low or high GI diets matched on total energy, macronutrient composition, and fiber content. Both groups received dietary counseling based on a small energy restriction (100–300 kcal/day). Women were classified in two groups according to their baseline HOMA-IR: IR (n = 64) and non-IR (n = 121). Results: At baseline, IR and non-IR groups had similar BMI (26.7 vs. 26.3 kg/m2; p = 0.21), but the IR group presented with higher waist circumference (82.7 vs. 80.8 cm; p = 0.02) and showed greater weight loss after 12 months of follow-up (–1.6 vs. –1.1 kg; p = 0.01), mainly among those in a high-GI diet (–2.1 vs. –1.0 kg; p = 0.005) compared to the non-IR group (–1.4 vs. –0.8 kg; p = 0.04). Conclusions: The high-GI group showed statistically significant higher reduction in body weight, mainly among those women with baseline IR . Low-GI diet did not facilitate weight loss neither in IR women nor in non-IR women.

Keywords:
Obesity, Overweight, Nutrition, Prevention, Insulin resistance
1.
Eckel RH: Insulin resistance: an adaptation for weight maintenance. Lancet 1992;340:1452–1453.
2.
Howard BV, Adams-Campbell L, Allen C, Black H, Passaro M, Rodabough RJ, Rodriguez BL, Safford M, Stevens VJ, Wagenknecht LE: Insulin resistance and weight gain in postmenopausal women of diverse ethnic groups. Int J Obes Relat Metab Disord 2004;28:1039–1047.
3.
Johnson MS, Figueroa-Colon R, Huang TT, Dwyer JH, Goran MI: Longitudinal changes in body fat in African American and Caucasian children: influence of fasting insulin and insulin sensitivity. J Clin Endocrinol Metab 2001;86:3182–3187.
4.
Wedick NM, Snijder MB, Dekker JM, Heine RJ, Stehouwer CD, Nijpels G, van Dam RM: Prospective investigation of metabolic characteristics in relation to weight gain in older adults: the Hoorn Study. Obesity (Silver Spring) 2009;17:1609–1614.
5.
Votruba SB, Jensen MD: Insulin sensitivity and regional fat gain in response to overfeeding. Obesity (Silver Spring) 2011;19:269–275.
6.
Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, McManus K, Champagne CM, Bishop LM, Laranjo N, Leboff MS, Rood JC, de Jonge L, Greenway FL, Loria CM, Obarzanek E, Williamson DA: Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009;360:859–873.
7.
Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, Bowling AC, Newman HC, Jenkins AL, Goff DV: Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981;34:362–366.
8.
Sichieri R, Moura AS, Genelhu V, Hu F, Willett WC: An 18-mo randomized trial of a low-glycemic-index diet and weight change in Brazilian women. Am J Clin Nutr 2007;86:707–713.
9.
Brand-Miller JC, Holt SH, Pawlak DB, McMillan J: Glycemic index and obesity. Am J Clin Nutr 2002;76:281S-285S.
10.
Flint A, Moller BK, Raben A, Pedersen D, Tetens I, Holst JJ, Astrup A: The use of glycaemic index tables to predict glycaemic index of composite breakfast meals. Br J Nutr 2004;91:979–989.
11.
Ludwig DS: The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002;287:2414–2423.
12.
Sloth B, Krog-Mikkelsen I, Flint A, Tetens I, Bjorck I, Vinoy S, Elmstahl H, Astrup A, Lang V, Raben A: No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet. Am J Clin Nutr 2004;80:337–347.
13.
Thomas DE, Elliott EJ, Baur L: Low glycaemic index or low glycaemic load diets for overweight and obesity. Cochrane Database Syst Rev 2007:CD005105.
14.
Vrolix R, Mensink RP: Effects of glycemic load on metabolic risk markers in subjects at increased risk of developing metabolic syndrome. Am J Clin Nutr 2010;92:366–374.
15.
Larsen TM, Dalskov SM, van Baak M, Jebb SA, Papadaki A, Pfeiffer AF, Martinez JA, Handjieva-Darlenska T, Kunesova M, Pihlsgard M, Stender S, Holst C, Saris WH, Astrup A: Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med 2010;363:2102–2113.
16.
Pittas AG, Roberts SB: Dietary composition and weight loss: can we individualize dietary prescriptions according to insulin sensitivity or secretion status? Nutr Rev 2006;64:435–448.
17.
Wolever TM, Mehling C: High-carbohydrate-low-glycaemic index dietary advice improves glucose disposition index in subjects with impaired glucose tolerance. Br J Nutr 2002;87:477–487.
18.
Pittas AG, Das SK, Hajduk CL, Golden J, Saltzman E, Stark PC, Greenberg AS, Roberts SB: A low-glycemic load diet facilitates greater weight loss in overweight adults with high insulin secretion but not in overweight adults with low insulin secretion in the calerie trial. Diabetes Care 2005;28:2939–2941.
19.
Foster-Powell K, Holt SH, Brand-Miller JC: International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 2002;76:5–56.
20.
Sichieri R, Everhart JE: Validity of a Brazilian food frequency questionnaire against dietary recalls and estimated energy intake. Nutr Res 1998;18:1649–1659.
21.
Geloneze B, Repetto EM, Geloneze SR, Tambascia MA, Ermetice MN: The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome study. Diabetes Res Clin Pract 2006;72:219–220.
22.
Swinburn BA, Nyomba BL, Saad MF, Zurlo F, Raz I, Knowler WC, Lillioja S, Bogardus C, Ravussin E: Insulin resistance associated with lower rates of weight gain in pima indians. J Clin Invest 1991;88:168–173.
23.
Porte D Jr, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW: Obesity, diabetes and the central nervous system. Diabetologia 1998;41:863–881.
24.
Evangelou P, Tzotzas T, Christou G, Elisaf MS, Kiortsis DN: Does the presence of metabolic syndome influence weight loss in obese and overweight women? Metab Syndr Relat Disord 2010;8:173–178.
25.
Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature 2006;444:881–887.
26.
Ali AT, Ferris WF, Naran NH, Crowther NJ: Insulin resistance in the control of body fat distribution: a new hypothesis. Horm Metab Res 2011;43:77–80.
27.
Ibrahim MM: Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010;11:11–18.
28.
Lafontan M, Berlan M: Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci 2003;24:276–283.
29.
Cornier MA, Donahoo WT, Pereira R, Gurevich I, Westergren R, Enerback S, Eckel PJ, Goalstone ML, Hill JO, Eckel RH, Draznin B: Insulin sensitivity determines the effectiveness of dietary macronutrient composition on weight loss in obese women. Obes Res 2005;13:703–709.
30.
McLaughlin T, Abbasi F, Carantoni M, Schaaf P, Reaven G: Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women. J Clin Endocrinol Metab 1999;84:578–581.
31.
Pittas AG, Roberts SB, Das SK, Gilhooly CH, Saltzman E, Golden J, Stark PC, Greenberg AS: The effects of the dietary glycemic load on type 2 diabetes risk factors during weight loss. Obesity (Silver Spring) 2006;14:2200–2209.
32.
Sigal RJ, El-Hashimy M, Martin BC, Soeldner JS, Krolewski AS, Warram JH: Acute postchallenge hyperinsulinemia predicts weight gain: a prospective study. Diabetes 1997;46:1025–1029.
33.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
34.
Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487–1495.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.